Abstract
In agreement with previous reports (Neal and Colley, Biochem. J., 174 (1978) 839; Gurtoo and Dave, Cancer Res., 35 (1975) 382) the capacity of isolated hepatic microsomes to metabolise aflatoxin B 1 (AFB 1) is enhanced by pretreatment in vivo with phenobarbitone. Microsomes isolated from rats pretreated with 3-methylcholanthrene also exhibit increased metabolism of AFB 1. The levels of metabolism are increased in proportion to the increased levels of cytochromes P-450 and P-448 indicating similar overall efficiencies of the two cytochromes to metabolise AFB 1. However, the qualitative aspects of the metabolism induced by the two compounds are very different. In agreement with the previous data (Neal and Colley, Biochem J., 174 (1978) 839) the formation of aflatoxins Q 1, M 1 and B 1-dihydrodiol are enhanced by pretreatment with phenobarbitone whereas pretreatment with 3-methylcholanthrene, while not affecting the production of aflatoxin Q 1 and slightly lowering AFB 1-dihydrodiol formation, increases the production of aflatoxin M 1 > 10-fold. Covalent binding of AFB 1 to microsomal protein in vitro is increased by pretreatment in vivo with phenobarbitone, but decreased by pretreatment with 3-methylcholanthrene. The changes in the level of protein binding in vitro brought about by these pretreatmens are quantitatively similar to the relative changes in AFB 1-dihydrodiol tris complex production induced by the two compounds indicating a role for this metabolite in protein binding. Covalent binding of AFB 1 to DNA in vitro is also increased by pretreatment in vivo with phenobarbitone, but not by 3-methylcholanthrene and the total level of binding of AFB 1 to DNA in the in vitro system is greater than binding to microsomal protein. The possible mechanisms for binding AFB 1 to microsomal protein and DNA are discussed. In contrast to the microsomal incubations, only low levels of aflatoxins Q 1 and M 1 are present after 2 h incubation AFB 1 with intact hepatocytes isolated from control, methylcholanthrene or phenobarbitone pretreated rats. Pretreatment with either phenobarbitone or 3-methylcholanthrene induces the formation of polar metabolites, presumably conjugates, emphasising the predominant role of phase 2 metabolism in intact cellular systems.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.